BAMCO Inc
ACAD icon

BAMCO Inc’s Acadia Pharmaceuticals ACAD Stock Holding History

BAMCO Inc’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-638,000
Closed -$22.7M – 296
2015
Q4 		$22.7M Hold
638,000
– – 0.11% 181
2015
Q3 		$21.1M Sell
638,000
-1,100
-0.2% -$45.8K 0.1% 191
2015
Q2 		$26.8M Buy
639,100
+32,000
+5% +$1.24M 0.11% 186
2015
Q1 		$19.8M Buy
607,100
+109,570
+22% +$3.77M 0.08% 212
2014
Q4 		$15.8M Sell
497,530
-4,570
-0.9% -$130K 0.06% 225
2014
Q3 		$12.4M Buy
502,100
+65,100
+15% +$1.52M 0.05% 227
2014
Q2 		$9.87M Sell
437,000
-55,442
-11% -$1.16M 0.04% 244
2014
Q1 		$12M Buy
+492,442
New +$12.5M 0.05% 217

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BAMCO Inc's ACAD Position: Q1 2016 in Review

BAMCO Inc sold out of Acadia Pharmaceuticals (ACAD) in Q1 2016, closing a stake of 638,000 shares — an estimated $22.7M sold.

BAMCO Inc first reported a position in ACAD in Q1 2014 and held it in 8 quarters. The position peaked at $26.8M in Q2 2015. 213 funds tracked by Wall St. Rank hold ACAD as of Q1 2016.

  • BAMCO Inc reported no remaining Acadia Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • BAMCO Inc sold 638,000 Acadia Pharmaceuticals shares in Q1 2016, an estimated $22.7M.
  • BAMCO Inc first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 8 quarters.
  • BAMCO Inc's Acadia Pharmaceuticals position peaked at $26.8M in Q2 2015.
  • 213 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2016.

Based on BAMCO Inc's 13F filing for Q1 2016, filed 16 May 2016.